ZA200705786B - Compositions for controlling parasites comprising synergic combination of amitraz and chlorpyrifos - Google Patents
Compositions for controlling parasites comprising synergic combination of amitraz and chlorpyrifos Download PDFInfo
- Publication number
- ZA200705786B ZA200705786B ZA200705786A ZA200705786A ZA200705786B ZA 200705786 B ZA200705786 B ZA 200705786B ZA 200705786 A ZA200705786 A ZA 200705786A ZA 200705786 A ZA200705786 A ZA 200705786A ZA 200705786 B ZA200705786 B ZA 200705786B
- Authority
- ZA
- South Africa
- Prior art keywords
- amitraz
- chlorpyrifos
- ppm
- composition
- animals
- Prior art date
Links
- 229960002587 amitraz Drugs 0.000 title claims description 52
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 title claims description 52
- 239000000203 mixture Substances 0.000 title claims description 50
- 239000005944 Chlorpyrifos Substances 0.000 title claims description 35
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 title claims description 35
- 244000045947 parasite Species 0.000 title claims description 18
- 230000002195 synergetic effect Effects 0.000 title description 3
- 241001465754 Metazoa Species 0.000 claims description 37
- 239000004480 active ingredient Substances 0.000 claims description 13
- 241000283690 Bos taurus Species 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000011885 synergistic combination Substances 0.000 claims description 2
- 239000013011 aqueous formulation Substances 0.000 claims 1
- 241000238876 Acari Species 0.000 description 21
- 238000011282 treatment Methods 0.000 description 19
- 230000000895 acaricidal effect Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 241000238680 Rhipicephalus microplus Species 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000004495 emulsifiable concentrate Substances 0.000 description 9
- 239000004563 wettable powder Substances 0.000 description 9
- 239000000642 acaricide Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 241001481703 Rhipicephalus <genus> Species 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 241000607479 Yersinia pestis Species 0.000 description 5
- 239000002917 insecticide Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- -1 4-xylyliminomethyl Chemical group 0.000 description 4
- 206010061217 Infestation Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000003071 parasitic effect Effects 0.000 description 4
- RCIJACVHOIKRAP-UHFFFAOYSA-N sodium;1,4-dioctoxy-1,4-dioxobutane-2-sulfonic acid Chemical compound [Na+].CCCCCCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCCCCCC RCIJACVHOIKRAP-UHFFFAOYSA-N 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- ZRYCRPNCXLQHPN-UHFFFAOYSA-N 3-hydroxy-2-methylbenzaldehyde Chemical compound CC1=C(O)C=CC=C1C=O ZRYCRPNCXLQHPN-UHFFFAOYSA-N 0.000 description 3
- 239000005946 Cypermethrin Substances 0.000 description 3
- 241000238889 Ixodidae Species 0.000 description 3
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 3
- 229960005424 cypermethrin Drugs 0.000 description 3
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000013020 final formulation Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000749 insecticidal effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 241000238888 Argasidae Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 238000010162 Tukey test Methods 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 2
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 2
- 239000002728 pyrethroid Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004544 spot-on Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 1
- HJTAZXHBEBIQQX-UHFFFAOYSA-N 1,5-bis(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1CCl HJTAZXHBEBIQQX-UHFFFAOYSA-N 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- 239000003148 4 aminobutyric acid receptor blocking agent Substances 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 241000238679 Amblyomma Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- AUKARGWOCYVKKC-UHFFFAOYSA-N CCOS(C(C(Cl)=C1)=NC(Cl)=C1Cl)(OCC)=P(O)(O)O Chemical compound CCOS(C(C(Cl)=C1)=NC(Cl)=C1Cl)(OCC)=P(O)(O)O AUKARGWOCYVKKC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 241001480824 Dermacentor Species 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- AIGRXSNSLVJMEA-UHFFFAOYSA-N EPN Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- FGIWFCGDPUIBEZ-UHFFFAOYSA-N Etrimfos Chemical compound CCOC1=CC(OP(=S)(OC)OC)=NC(CC)=N1 FGIWFCGDPUIBEZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- OVGORFFCBUIFIA-UHFFFAOYSA-N Fenipentol Chemical compound CCCCC(O)C1=CC=CC=C1 OVGORFFCBUIFIA-UHFFFAOYSA-N 0.000 description 1
- 239000005898 Fenoxycarb Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- AIKKULXCBHRFOS-UHFFFAOYSA-N Formothion Chemical compound COP(=S)(OC)SCC(=O)N(C)C=O AIKKULXCBHRFOS-UHFFFAOYSA-N 0.000 description 1
- 239000005959 Fosthiazate Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001480803 Hyalomma Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000238681 Ixodes Species 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 208000006123 Myiasis Diseases 0.000 description 1
- 241001480756 Otobius megnini Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001649231 Psoroptidae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N arsenic trioxide Inorganic materials O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 1
- 229960003997 doramectin Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 1
- 210000001981 hip bone Anatomy 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
- 229960004816 moxidectin Drugs 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 239000002297 parasiticide Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- PWYIUEFFPNVCMW-UHFFFAOYSA-N propaphos Chemical compound CCCOP(=O)(OCCC)OC1=CC=C(SC)C=C1 PWYIUEFFPNVCMW-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940108410 resmethrin Drugs 0.000 description 1
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OPASCBHCTNRLRM-UHFFFAOYSA-N thiometon Chemical compound CCSCCSP(=S)(OC)OC OPASCBHCTNRLRM-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 201000001064 tick infestation Diseases 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000018405 transmission of nerve impulse Effects 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/52—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing groups, e.g. carboxylic acid amidines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Description
COMPOSITIONS FOR CONTROLLING PARASITES COMPRISING SYNERGIC
COMBINATION OF AMITRAZ AND CHLORPYRIFOS
The present invention relates to compositions for controlling parasites and the use of such compositions in the preparation of a medicament for controlling acarine parasites.
Ticks are important blood feeding arthropod parasites that belong together with mites (Family: Psoroptidae) to the order Acarina (acarine parasites). There are two well- established familias of ticks, the Ixodidae (hard ticks), and Argasidae (soft ticks). The
Ixodidae species is of most economic importance and include the important species
Boophilus spp., Rhipicephalus spp, Ixodes spp, Hyalomma spp., Amblyomma spp. and Dermacentor spp.
The cattle tick Boophilus microplus is the most economically important bovine parasite in Brazil, causing economic losses in the order of US$ 2 billion each year (Grisi et al., 2002). Furlong et al. (2004) assert that this parasite causes severe damage by its direct action, provoking anemia, myiasis predisposition, leather depreciation, as well as by its indirect action, characterized by haemoparasites inoculation and costs from chemical treatment. Bovine development and production are highly damaged by B. microplus, and its control varies, according to climatic conditions (Oliveira et al., 1973) and breed of the animals (Verissimo, 1990).
Each of the five Boophilus spp. has a one-host life cycle that may be completed in 3 to 4 weeks and results in a heavy tick burden. Treatment of hosts with acaricides to kill attached larvae, nymphs, and adults of ticks has been the most widely used control method. Chemical products are the major way of control of ticks. In the first half of the 20" century, the main acaricide was arsenic trioxide. Subsequently, organochlorines, organophosphates, carbamates, amidines, pyrethroids, and avermectins have been used in different parts of the world.
However, its frequent utilization led to resistant parasite population selection.
Acaricide products resistance is widespread in the world and contemplates a lot of chemical products (Kunz & Kemp, 1994).
Thus, acaricide products inefficacy is very common. The first case of organophosphate resistant Boophilus microplus in Brazil was reported in Santa
Ambrésia, Rio Grande do Sul, in 1963 (Wharton & Roulston, 1975), and its isolated use for ticks control was stopped in 1976 in the south of Brazil. In relation to synthetic h 2 pyrethroids, resistance was firstly identified in Sao Paulo (Pereira & Lucas, 1987),
Rio de Janeiro (Leite, 1988) and Rio Grande do Sul (Laranja et al., 1989) states.
Strains of ticks were shown resistant to amitraz in Rio de Janeiro state (Gloria et al., 1993; Flausino et al., 1995) and Rio Grande do Sul (Martins et al., 1995; Vargas et al. 2003). In the macrocydic lactones group, Martins and Furlong (2001) have already verified bad efficacy of doramectin, moxidectin and ivermectin against
Boophilus microplus.
Chemical parasiticides are a non renewable resource, and as resistance is installed, it looses its utility forever, as the phenomenon is unchangeable. So, prudent use is recommended to take advantage of the products for a longer time. Different drugs combination is a suggested strategy to overcome resistance (FAO, 2003). In this kind of treatment, ticks are exposed to more than one active. A necessary condition for drugs combination efficacy is that there is no crossed resistance between the actives, i.e. that the action mechanisms and metabolic ways are different (Kunz & Kemp, 1994).
However, to obtain an acaricidal composition which shows no cross-resistance with existing insecticidal and acaricidal agents, has no toxicity problems and has little negative impact on the environment, is extremely difficult. Therefore, a means to delay or prevent the development of resistant strains of pest species is always being sought. In order to apply an effective agent as long as possible, a rotational application of agents with different mechanisms of action is adopted for good pest management practice.
However, this approach does not necessarily give satisfactory pest control.
Therefore, after a resistance problem has occurred, a countermeasure to resistance by combining insecticidal and acaricidal agents has been studied. However, a high synergistic action has not always been found.
Therefore, it is an object of this invention to provide an acaricidal composition which demonstrates a high controlling effect even against ticks of Boophilus sp., which acquired resistance against amitraz and/or certain organophosphate compounds.
The invention thus relates to a veterinary composition for the control of acarine parasites on animals comprising as active ingredient a synergistic combination of amitraz and chlorpyrifos.
Amitraz is a known insecticide and acaricide and is the common name for N,N-bis (2 4-xylyliminomethyl)methylamine. Amitraz presents adrenergic activity by monoaminoaxidasis inhibition, leading to noradrenalin and serotonin at central nervous system.
Organophosphate compounds are for a long time used as insecticide and pesticide for plants and livestock as well as anthelmintic for animals. The acaricidal action of organophosphate compounds is due to the inhibition of the enzyme acetylcholinesterase, resulting in the accumulation of the neurotransmitter acetylcholine, at nerve endings. This results in excessive transmission of nerve impulses, which causes mortality in the target pest.
Examples of organophosphate compounds are Profenofos, Dichlorvos, Fenamiphos,
Fenitrothion, EPN , Diazinon Chlorpyrifos, Acephate, Prothiofos, Fosthiazate,
Cadusafos, Dislufoton Isoxathion, Isofenphos, Ethion (!), Etrimfos, Quinalphos,
Dimethylvinphos, Dimethoate, Sulprofos, Thiometon, Vamidothion, Pyraclofos
Pyridaphenthion, Pirimiphos-methy,| Propaphos, Phosalone, Formothion, Malathion,
Tetrachlovinphos, Chlorfenvinphos, Cyanophos ,Trichlorfon, Methidathion,
Phenthoate, Dimethylethyisulfilisopropyl thiophosphate (common name: ESP),
Azinphos-methyl, Fenthion, Heptenophos, Methamidphos, Paration.
Especially preferred is Chlorpyrifos. The chemical name of chlorpyrifos is 0,0 -
Diethyl-O-3,5,6-trichloro-2-pyridylphosphorothioate.
For the preparation of the composition of the invention, it is suitable to formulate the composition e.g. as a wettable powder, aqueous concentrate, emulsifiable concentrate (EC), liquid concentrate, sol (flowable agent), powder, aerosol, or the like, by conventional methods such as admixing the compounds separately with a suitable carrier and auxiliaries, such as emulsifiers, dispersants, stabilizers, suspending agents, penetrants, and the like and than combine the formulations for direct administration to the animal, optionally after diluting.
Amitraz is preferably formulated as wettable powder and the organophosphate compound (e.g. chlorpyrifos) as emulsifiable concentrate and the final composition is mixed with water immediately before application to the animal. .
Alternatively amitraz and the organophosphate compound (e.g. chlorpyrifos) are formulated as wettable powder and mixed with water immediately before application to the animal to form the final formulation.
An emulsifiable concentrate comprises the active ingredient dissolved in water- immiscible solvent which is formed into an emulsion with water in the presence of an emulsifying agent.
A dispersible or wettable powder usually comprises the active ingredients in admixture with a suitable surfactant and an inert powder diluent such as china clay.
Suitable formulations are usually composed of 0.001 to 99 parts by weight, preferably 0.01 to 95 parts by weight, more preferably 0.01 to 80 parts by weight of an active ingredient and 1 to 99.999 parts by weight, preferably 5 to 99.99 parts by weight, more preferably 20 to 99.99 parts by weight of suitable carrier and auxilliaries.
The composition may be formulated for application by a particular method, for example spraying, in which case the formulation may be presented as an aerosol using a liquid or gas propellent.
As the suitable carrier and auxiliaries, there may be mentioned carriers, emulsifiers, suspending agents, dispersants, extenders, penetrating agents, wetting agents, thickeners, defoaming agents, stabilizers or antifreezing agents. They may be added as the case requires.
The ratio of the organophosphate compound to amitraz in the acaricidal composition of the invention is about 1 weight part of the amitraz to about 0.5-10 weight parts, preferably about 1-5 weight parts, of the organophosphate compound
In commercially useful formulations, the composition of the invention may also be present in a mixture with other active agents, for example various insecticidal, or acaricidal agents in order to expand its applicability. Such pesticide compounds may include active ingredients which have an immediate effect, rather than the relatively slowly acting IGR. Other ingredients that may be included in the composition of the current invention are pesticidial active ingredients e.g. synthetic pyrethroids ( e.g permethrin, deltamethrin, cypermethrin, lambdacyhalothrin, fenvalerate, resmethrin, tralomethrin), acetyicholinesterase Inhibitors as carbamates (e.g. carbaryl,
n 5 benziocarb, fenoxycarb, proxopur), acetylcholine mimics (e.g. nicotine, imidacioprid),
GABA Antagonists (e.g. fipronil).
In another embodiment the invention relates to the use of the composition according to the invention for the manufacture of a veterinary medicament for the control of parasites, especially parasitic acarid- infestations on host animals.
In example 3 the therapeutic efficacy and residual period of the composition according to the invention was evaluated, after spray administration of the water- diluted composition manufactured according to example 1 to Boophilus microplus infested cattle in different Brazilian regions. These experiments conducted in cattle demonstrated that the association showed a higher efficacy against ticks of
Boophilus sp., when compared to the efficacy of the separate compounds.
The compositions of the invention are intended for use for controlling a parasitic acarid infestation. The term “controlling a parasitic acarid infestation” refers to preventing, reducing or eliminating an infestation by such parasites on animals preferably by killing the insects and/ or acarids within hours or days.
The term “parasitic acarid” refers to ectoparasites e.g. acarine pests that commonly infest or infect animals. Examples of such ectoparasites include the egg, larval, pupal, nymphal and adult stages of mites and ticks.
Various techniques for administration to the animal are available. When pasture or lot conditions and management systems are favourable, animals may be dipped in a bath with water diluted acaricide. Dipping vats are constructed so that animals are thoroughly immersed in the vat fluid, and the liquid that drains from the animals, returns to the vat.
Aqueous emulsions or suspensions may also be applied by spraying. Sprayers are generally portable and may be hand- or motor-driven, and only enough acaricide to treat a specific number of animals needs be prepared. Hand application of insecticides as washes, ointments, dusts, mist sprays, spray foams, aerosols, etc, can also be done.
Ear ticks may be controlled by insecticides applied directly into the ears. Other treatments applied by hand include the pour-on method, which consists of applying a water-diluted, emulsifiable concentrate or a ready-to-use formulation. The liquid should be poured along the backline from the shoulders to the hip bones. The spot-on treatment method consists of applying a small volume of concentrated insecticide to a single spot on the animal's back
The compositions of the invention may be employed in many forms and are often most conveniently prepared in aqueous form immediately prior to use.
One method of preparing such a composition is referred to as “tank mixing” in which the ingredients in their commercially available form are mixed together by the user in a quantity of water.
In addition to tank mixing immediately prior to use the compositions containing amitraz and the organophosphate may be formulated into a more concentrated primary composition which is diluted with water or other diluent before use. Such compositions may comprise a surface active agent in addition to the active ingredients.
It can be a dispersable solution which comprises the active ingredient dissolved in a water-miscible solvent with the addition of a disperging agent. Altematively it can comprise the ingredients in the form of a finely ground powder in association with a disperging agent and intimately mixed with water
For preparation of the final formulation for administration to the animal the active ingredients are diluted in water. The final concentration of amitraz and the organophosphate in the diluted ready to use formulation is between 50 ppm and 800 ppm. In a preferred embodiment the diluted composition contains 250 ppm amitraz and 500 ppm chlorpyrifos. The diluted composition is preferably administered to the animal by spray or dip. Preferably 5 liters of the diluted composition are applied to each animal.
Preferably, the active ingredients are formulated separately and they are mixed together immediately before administration to the animal.
Preferably the host animal is a bovine. The method may be also be used to treat or control parasites on a variety of other animals including livestock animals as sheep, . deer, goats, pigs, and companion animals as horses, dogs and cats.
The composition according to the invention is used to control acarine parasites on animals, especially for the control of ticks, especially Boophilus sp..
The composition of the invention is further illustrated in the following examples.
FAO. Resistencia a los antiparasitarios: estado actual con énfasis en América Latina.
Roma: FAO, Salud Animal, p. 1-52, 2003.
FLAUSINO, J.RN.; GOMES, C.C.G.; GRISI, L. Avaliagdo da resisténcia do carrapato B. microplus a piretréides no municipio de Seropédica, Rio de Janeiro. In:
Seminario Brasileiro de Parasitologia Veterinaria, 8. 1995. Campo Grande.
Anais...Campo Grande. 1995. p. 45.
FURLONG, J.; MARTINS, J.R.S,;PRATA, M.C.A. Controle estratégico do carrapato dos bovinos. A Hora Veterinaria , ano 23, n. 137, p. 53-56, 2004.
GLORIA, M.A; FLAUSINO, J.RN.; GRIS), L. Resisténcia do Boophilus microplus ao amitraz no estado do Rio de Janeiro, com base em testes de imersdo de fémeas ingurgitadas. In: Seminario Bras. de Parasitologia Veterinaria, 7., 1993, Londrina. Anais...Londrina. 1993. p. A7.
GRIS!, L. et al. Impacto econdmico das principais ectoparasitoses em bovinos no
Brasil. A Hora Veterinaria , ano 21, n. 125, p. 8-10, 2002.
KUNZ, E.S.; KEMP, H.D. Insecticides and acaricides: resistance and environmental impact. Rev. Sci. Tech. OF. Int. Epiz. v.13, .4, p.1249-1286, 1994.
LARANJA, R.J.; MARTINS, J.R.; CERESERV, H.; CORREA, B.L; FERRAZ, C.
Identificacdo de uma estirpe de Boophilus microplus resistente a carrapaticidas piretréides no Estado do Rio Grande do Sul. In: Seminério Brasileiro de Parasitologia
Veterinaria, Bagé, 1989, Bagé. Anais...1989. p.83.
LEITE, C.L. Boophilus microplus (can.1887): Susceptibilidade, uso atual e retrospectivo de carrapaticida em propriedades das regibes fisiogeogréficas da baixada do grande-Rio e Rio de Janeiro, uma abordagem gpidemiolégica. Rio de
Janeiro. UFRRJ. 1988. 122p. Tese (Doutorado). Universidade Federal Rural do Rio de Janeiro. 1988.
MARTINS, JR; FURLONG, J. Avermectin resistance of the cattle tick Boophilus microplus in Brazil. Veterinary Record, v. 149, n. 2, p. 64, 2001.
MARTINS, J.R.S. CORREA, B.L.; CERESER, V.H.; ARTECHE, C.C.P.A. Situation report on resistance to acaricides by the cattle tick Boophilus microplus in the state of
Rio Grande do Sul, southern Brazil. In: Seminério International de Parasitologia
Animal, 3. Anais... Acapulco, México, 1995.
OLIVEIRA, G.P.; PAULA COSTA, R.; MENEGUELI, CA. MELLO, R.P. Estudo ecolégico da fase nao parasitdria do Boophilus microplus (Canestrini, 1889) (Acarina: Ixodidae) no Rio de Janeiro. Arquivos da Universidade Federal do Rio de :
Janeiro, v.4,n.1, p. 1-10, 1974.
PEREIRA, M.C.; LUCAS, R. Estudos in vitro da eficiéncia de camrapaticidas em linhagem de Boophilus microplus proveniente de Jacarel, SP, Brasil. Rev. Fac. Med.
Vet. Zoo. USP., v.24, n.1, p. 7-11, 1987.
ROULSTON, W.J.; STONE, B.F; WILSON, J.T.; WHITE, L.T. Chemical control of an organophosphorus and carbamate-resistant strain of Boophilus microplus (Can.) from Queensland. Bulletin of Entomology Research., v.58, p.379-392, 1968.
VARGAS, M.S.; CESPEDES, N.S. SANCHES, H.F.; MARTINS, JR CESPEDES,
C.0.C.. Avaliaggo in vitro de uma cepa de campo de Boophilus microplus (Acari:Ixodidae) resistente a amitraz. Ciéncia Rural, v.33, n.4, p. 737-742, 2003.
VERISSIMO, C.J. Estudo da resisténcia e susceptibilidade do carrapato bovino (Boophilus microplus) em rebanho mestigo. Jaboticabal, 1990. 163p. Dissertacéo (Mestrado em Zootecnia, Area de Concentragéo em Produgso Animal), 1990.
WHARTON, R.H.; ROULSTON, W.J. Acaricide resistance in Boophilus microplus in
Australia. Hemoparasite Workshop. Cali, Colombia. Centro International de
Agricultura Tropical. 1975.
WHARTON, R.H.; ROULSTON, W.J.; UTECH, K.B.W.; KERR, J.D. Assessment of the efficiency of acaricides and their mode of application against the cattle tick
Boophilus microplus. Australian Journal of Agriculture Research, v.21, p.985-1006,
Example 1: Preparation of the composition amitraz wettable powder + chiopyrifos EC 1) Amitraz wettable powder:
Composition for 100 g:
Amitaz technical 50.000g
Paraformaldehyde 300g
Cresol formaldehyde sulfonate condensate 10.009
Aerosol OT-B 1.009
Amorphous alumina silicate 19.00 ¢
Precipitated calcium carbonate up to 100.009 2) Chlorpyrifos emulsifiable concentrate (EC)
Composition for 100 ml:
Chlorpyrifos 50.009
Calcium phenyisulpfonate 3.50¢9 *Nonilphenol 6 EO (etoxylated) 6.759
Ester polyglycolic of fatty acid 36 EO (etoxylated) 3.25g
Soybean oil epoxylated 1.00g
Butyl hydroxytoluen 0.0104¢
Solvesso 150 44.0409 *Brand name: Renex 60 (from Oxiteno)
Brand name: Surfom 400 (from Oxiteno)
For preparation of the final formulation for administration to the animal the active ingredients are diluted in water. The two active ingredients are formulated separately and they are mixed just before use.
To get 20 liter of the diluted composition containing amitraz 250 ppm + chlorpyrifos 500 ppm in water, the amount of each formulation is: 10 g of amitraz wp and 20 mL of chlorpyrifos EC. Then it is administrated over the animal by spraying on or dip.
Example 2: Preparation of the composition amitraz wp + chlopyrifos wettable powder 1) Amitraz wettable powder (wp):
Composition for 100 g:
Amitaz technical 50.009
Paraformaldehyde 3.00g
Cresol formaldehyde sulfonate condensate 10.00g
Aerosol OT-B . 1.009
Amorphous alumina silicate 19.009
Precipitated calcium carbonate up to 100.00g 2) Chlorpyrifos wettable powder (wp):
Composition for 100 g
Chilorpyrifos 50.00¢
Cresol formaldehyde sulfonate condensate** 1000 g
Aerosol OT-B* 1009
Starch up to 100.00g *Aerosol OT-B is ducosate sodium which is an anionic surfactant ** suspending agent.
To get 20 liter of the diluted composition containing amitraz 250 ppm + chlorpyrifos 500 ppm in water, the amount of each formulation is: 10 g of amitraz wp and 20 g of chlorpyrifos wp.
Example 3: Efficacy of amitraz + chlorpyrifos composition against tick infestation of cattle
Material and methods: Six experiments were conducted to evaluate the therapeutic efficacy and residual period of the amitraz + chlorpyrifos association prepared according to example 1. In all of them, the same methodology was used, as described below.
Three counts of ticks between 4.5 and 8.0 mm of diameter on the left side of naturally infested bovine were performed on three consecutive days. The animals were grouped by the means of the counts, constituting groups of 10 animals with similar average number of ticks (Wharton et al., 1970). Treatments were randomly attributed to the groups, with one kept as control, without any administration of tickicide product.
The treatments for each experiment are listed on Table 1. In all the cases, the bovine was sprayed with the product after its dilution, in a quantity of at least 5 liters per animal.
Table 1: Description of the experiments, describing tested products and sites of execution.
Experiment Local Treatments (dilution) —__ Amitaz (250 ppm) + Chiorpyrifos (500 ppm)
Findamonhangaba. Chorpyrifos (500 ppm)
Co Amies@0pem —————— Amiraz (250 ppm) + chlorpyrifos (500 ppm) 1 Formiga, MG -_
Amitraz (250 ppm)
ES ——————
El
FLT
~~ Amitraz (250 ppm) + chlorpyrifos (500 ppm) \Y% Cassia, MG ~~ Flumethrin (30 ppm) + coumaphos (400 ppm)
For the products tickicide effect estimative, new counts were done on days +1, 43, +7, post treatment and then weekly, until significant efficacy could be perceived.
Efficacy was calculated by the methodology proposed by Rouiston et al. (1968), considering geometric means of the counts of each group:
Efficacy = 100 x 1 — (Tax Cb) / (Tb x Ca)
Ta — mean count in treatment group on a specific day
Tb — mean count in treatment group on day zero
Ca — mean count in control group on a specific day
Cb — mean count in treatment group on day zero (day zero was considered as the average count of the three previous days).
Statistical analysis was conducted after data logarithm transformation (Little & Hills, 1978), applying F test, and comparing the means with Tukey test.
Ticks counts and efficacy values of treated and control animals in Experiments |, Hl,
I, IV, V and VI are shown in Table 2.
Results and Discussion: Geometric means of left side sited 4.5 to 8 mm Boophilus microplus female counts in all the experiments, as well as efficacy perceptual of the evaluated products, are presented on Table 2. Efficacy values are illustrated on
Graph 1
Comparison of efficacy of the association and the isolated actives
In experiment 1, the efficacy of the association was compared to the efficacy of the isolated actives. Ticks counts in chlorpyrifos + amitraz treated animals differed from the control group from day + 1 to day +21 post treatment. Expressive efficacy of isolated chlorpyrifos was seen only until day +7. Amitraz presented almost no efficacy, and the counts in this group didn't differ from control group from day + 14.
Amitraz results were very poor, making evident the occurrence of resistance against this active. Thus, the association performance was highly better than when the actives were administered at isolated form.
The association was compared to amitraz in three experiments (Ii, lil and IV). In all of them, ticks counts for association treated animals differed from control from day +1 to day +28 post treatment, reflecting its expressive effectiveness. Statistical difference between the association and amitraz treatments is shown on days +21 (Exp il), +7 and +14 (Exp Il and IV) and +3 (Exp. IV). Taking these experiments together, it can be presumed that amitraz resistant tick strains are present. However, when the active is associated to chlopyrifos, good control could be obtained.
Comparison between chlorpyrifos + amitraz and some pyrethroid+ organophosphorous associations
The combination of chlorpyrifos + amitraz was compared in experiments V and Vi to some commercially available pyrethroid+ organophosphorous associations on
Brazilian market. In experiment V, higher values of efficacy were seen from amitraz+ chlorpyrifos than from flumethrin+ coumaphos, although it could not be demonstrated statistically. In this experiment, amitraz treated animals presented higher number of ticks (p<0,05) on days +3 and +21 post treatment than amitraz+ chlorpyrifos treated ones, corroborating the efficacy of the new association on amitraz resistant tick strains.
In experiment VI, 100% of efficacy was presented by amitraz+ chlorpyrifos from day +3 to day + 21. It caused higher reduction in tick amounts than cypermethrin+ ethion on days +3, +21, +28 and +35 post treatment.
When all the experiments results are considered, it can be concluded that the combination of amitraz+chlorpyrifos improved has improved efficacy over the single compounds amitraz and chlorpyrifos, acting even against amitraz resistant ticks.
Considering the problem represented by acaricide resistant Boophilus microplus in
Brazil, this association is a useful approach in the control of this important parasite in bovine animals.
Table 2: Geometric means of Boophilus microplus female counts (between 4.5 and 8.0 mm of diameter) in bovine, and efficacy percentage
TREATMENT EXP Days post treatment / Number of B. microplus female ticks (Efficacy %)
CONTROL 60,20° 51,40° 66,40" 83,80° 18,00" 42,30*
Amitraz (250 ppm) + 62,10" 6.50 0,70° 0,20° 0,80° 10,80" chlorpyrifos (500 ppm) (87.80%) (09,00%) (88.70%) (95.80%) (76.20%) ' ! 6320° 990° 2,10° 2,60° 5,00° 24,60°
Chlomyrfos (S00 ppm) (860%) (96,00%) (97.00%) (73.30%) (44,60%) . 6470° 42,60° 23.40° 38,00 9,10% 44,30° 0
Amitraz (250 ppm) (22.80%) (67.20%) (57.80%) (52.80%) (2.50%)
CONTROL 3001° 5932 30,12° 27,82" 3528" 66.30° 50,79
Amitraz (250 ppm) + 3343 20,04° 468° 2,90° 9,70° 1,59° 7,23° chiompyrifos (500 ppm) i (67.35%) (85.62%) (00,35%) (74,57%) (97.78%) (86.83%) . 30,18" 18,03° 18,02° 6,11° 17,08° 11,18" 21,69°
Al 250 |] il ) |) 1 E) f) mitraz (250 ppm) (67.29%) (38.68%) (77.46%) (47.81%) (B271%) (56.22%) — CONTROL ——505° 81.57% 80,3 40,19 563,32" 16.17% 40,65
Amitraz (250 ppm) + 44,79 17.27° 217° 0,07° 0,28° 0,15° 1061° chlorpyrifos (500 ppm) m (79.18%) (97.34%) (99.82%) (99.48%) (99.00%) (74,33%) 4421° 13,08° 2,45° 344° 4,88° 0,89° 15,00°
Aniitraz (250 ppm) (83.02%) (95.23%) (89.24%) (88.42%) (92.50%) (48.87%)
CONTROL 38,38* 27.20° 28,49° 3389" 3674° 7080" 8228"
Amitraz (250 ppm) + 37,03* 6,97° 161° 0,87° 2,73¢ 083° 50,64° chlorpyrifos (500 ppm) wv (74.06%) (94,28%) (97.41%) (92.48%) (98.81%) (37.71%)
Amitraz (250 ppm) 3s80* 880° 6,06" 591° 1254> 168° 59,99 (67.97%) (78,95%) (B2,74%) (66,23%) (87.69%) (27.88%)
CONTROL 31,68° 26.48° 11,56* 17,56* 37.98’ 9,12
Amitraz (250 ppm) + 32,43° 2,66° 0,95° 0,00° 0,32° 0,15° chlorpyrifos (500 ppm) {90,21%) (91,99%) (100,00%) (99,17%) (88,39%)
Flumethrin (30 ppm) + v 29,55° 7.75° 2,01° 1,16° 1,06% 032° coumaphos (400 ppm) (68.72%) (81,41%) (92.94%) (97.04%) (96,25%) 30,15* 2,50° 0,78° 043° 2,01° 0,58°
Ami " i) t] 0) 1) ') traz (250 ppm) (90,11%) (92,93%) (97.43%) (94,45%) (93,33%)
CONTROL 27,03" 30,09" 44,06" 26,79" 28,29" 2811" 31,64° 9,94"
Amitraz (250 ppm) + 29,09° 383° 0,00° 0,00° 0,00° 0,00° 449° 2,62° chiorpyrifos (500 ppm) vi (87.79%) (100,00%) (100,00%) (100,00%) (100,00%) (86,38%) (74.72%)
Cypermethrin (80 ppm) 29,26° 8,16° 277° 091° 0,12 1,84° 34,24* 18,95° + gthion (600 ppm) (74.11%) (94,00%) (96,75%) (99.60%) (93.76%) (0.00%) (0.00%)
Means followed by at least a common letter, in the rows, don't differ by Tukey Test (P>0,05)
Claims (6)
1. A veterinary composition for the control of acarine parasites on animals comprising as active ingredient a synergistic combination of amitraz and chlorpyrifos.
2. The composition according to claim 1, characterized in that the ratio of amitraz : chlorpyrifos is from 1 to 0.5-10 by weight.
3. The composition according to claims 1 or 2, characterized in that it is a liquid aqueous formulation
4. Use of a composition according to any of claims 1 to 3 for the preparation of a medicament for controlling acarine parasites on host animals.
5. Use according to claim 5, characterized in that the host animal is a bovine.
6. Use according to claims 5 or 6 characterized in that the acarine parasite is a tick.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05100739 | 2005-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200705786B true ZA200705786B (en) | 2008-05-28 |
Family
ID=34938628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200705786A ZA200705786B (en) | 2005-02-03 | 2007-07-13 | Compositions for controlling parasites comprising synergic combination of amitraz and chlorpyrifos |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR053804A1 (en) |
BR (1) | BRPI0606794A2 (en) |
WO (1) | WO2006082213A1 (en) |
ZA (1) | ZA200705786B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102630701A (en) * | 2012-04-11 | 2012-08-15 | 苏州佳辉化工有限公司 | Environment-friendly pesticide containing chlorpyrifos and preparation method thereof |
CN110312424A (en) * | 2017-01-09 | 2019-10-08 | 澳大利亚国立大学 | For improving insecticide synergist |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9624501D0 (en) * | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Insecticial compositions and method |
DK0979605T3 (en) * | 1998-08-07 | 2003-06-23 | Pfizer Prod Inc | Collar containing a new gel formulation to combat arthropod attack on animals |
-
2006
- 2006-02-02 AR ARP060100372A patent/AR053804A1/en not_active Application Discontinuation
- 2006-02-02 BR BRPI0606794-8A patent/BRPI0606794A2/en not_active Application Discontinuation
- 2006-02-02 WO PCT/EP2006/050614 patent/WO2006082213A1/en not_active Application Discontinuation
-
2007
- 2007-07-13 ZA ZA200705786A patent/ZA200705786B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR053804A1 (en) | 2007-05-23 |
WO2006082213A1 (en) | 2006-08-10 |
BRPI0606794A2 (en) | 2010-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
George et al. | Chemical control of ticks on cattle and the resistance of these parasites to acaricides | |
AU775911B2 (en) | Pour-on formulations | |
SK282730B6 (en) | Insecticidal combinations including an insecticide from the chlor onicotinyl family and an insecticide having a pyrazole, pyrrole o r phenylimidazole | |
JPH0629161B2 (en) | Ectoparasiticidal preparation, its manufacturing method and ectoparasite control method | |
AU2009100496A4 (en) | Combination product for controlling insect pests | |
ZA200705786B (en) | Compositions for controlling parasites comprising synergic combination of amitraz and chlorpyrifos | |
Barbieri et al. | Field efficacy of Metarhizium anisopliae oil formulations against Rhipicephalus microplus ticks using a cattle spray race | |
JP4972843B2 (en) | Transdermal agent for controlling animal ectoparasites | |
US5750514A (en) | Method for controlling ectoparasites | |
US10064411B1 (en) | Ectoparasiticidal formulations | |
EP2053917B1 (en) | Composition for enhanced antiparasitic activity | |
EP3760045A1 (en) | Topical composition against rhipicephalus (boophilus) microplus | |
Jaishankar et al. | Effect of Flumethrin for Tick Control in Indigenous Bullocks | |
ARY | of these parasites to acaricides | |
WO2010048891A1 (en) | Method of preventing and killing ectoparasites of endotherm by combined application of amitraz and bifenthrin | |
WO2000047048A1 (en) | Pesticide treatment | |
AU2783700A (en) | Pesticide treatment |